These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 29752805)

  • 1. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
    Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
    Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells.
    Miao Y; Lu M; Yan Q; Li S; Feng Y
    Oncol Res; 2016 Oct; 24(6):463-475. PubMed ID: 28281967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M2 isoform of pyruvate kinase (PKM2) is upregulated in Kazakh's ESCC and promotes proliferation and migration of ESCC cells.
    Liu Q; Liang M; Liu T; Vuitton L; Zheng S; Gao X; Lu M; Li X; Sheyhidin I; Lu X
    Tumour Biol; 2016 Feb; 37(2):2665-72. PubMed ID: 26404132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
    Zheng B; Geng L; Zeng L; Liu F; Huang Q
    Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the Ubiquitin-Specific Peptidase 9 X-Linked (USP9X) Gene is Associated with Upregulation of Cyclin D1 (CCND1) and Downregulation of Cyclin-Dependent Inhibitor Kinase 1A (CDKN1A) in Breast Cancer Tissue and Cell Lines.
    Li H; Zheng B
    Med Sci Monit; 2019 Jun; 25():4207-4216. PubMed ID: 31169265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer.
    Liang F; Li Q; Li X; Li Z; Gong Z; Deng H; Xiang B; Zhou M; Li X; Li G; Zeng Z; Xiong W
    Int J Oncol; 2016 Sep; 49(3):1046-56. PubMed ID: 27573352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PKM2 Gene Silencing on the Proliferation and Apoptosis of Colorectal Cancer LS-147T and SW620 Cells.
    Ao R; Guan L; Wang Y; Wang JN
    Cell Physiol Biochem; 2017; 42(5):1769-1778. PubMed ID: 28746922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma.
    Zhang R; Shen M; Wu C; Chen Y; Lu J; Li J; Zhao L; Meng H; Zhou X; Huang G; Zhao X; Liu J
    Cell Death Dis; 2020 Dec; 11(12):1036. PubMed ID: 33279948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
    Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
    Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K
    Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
    Yuan Q; Yu H; Chen J; Song X; Sun L
    Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
    Shiroki T; Yokoyama M; Tanuma N; Maejima R; Tamai K; Yamaguchi K; Oikawa T; Noguchi T; Miura K; Fujiya T; Shima H; Sato I; Murata-Kamiya N; Hatakeyama M; Iijima K; Shimosegawa T; Satoh K
    Cancer Sci; 2017 May; 108(5):931-940. PubMed ID: 28235245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
    Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
    Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STIP1 down-regulation inhibits glycolysis by suppressing PKM2 and LDHA and inactivating the Wnt/β-catenin pathway in cervical carcinoma cells.
    Li R; Li P; Wang J; Liu J
    Life Sci; 2020 Oct; 258():118190. PubMed ID: 32777299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells.
    Li S; Ji X; Wang R; Miao Y
    Arch Gynecol Obstet; 2019 May; 299(5):1443-1451. PubMed ID: 30809696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer.
    Li J; Huang H; Li Y; Li L; Hou W; You Z
    Oncol Rep; 2016 Dec; 36(6):3241-3250. PubMed ID: 27779700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldolase A promotes proliferation and G
    Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
    Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Pyruvate Kinase M2 Expression with Clinicopathological Data in Ovarian Cancer.
    Kobierzycki C; Piotrowska A; Latkowski K; Zabel M; Nowak-Markwitz E; Spaczynski M; Kedzia W; Pula B; Podhorska-Okolow M; Dziegiel P
    Anticancer Res; 2018 Jan; 38(1):295-300. PubMed ID: 29277786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma.
    Shang Y; He J; Wang Y; Feng Q; Zhang Y; Guo J; Li J; Li S; Wang Y; Yan G; Ren F; Shi Y; Xu J; Zeps N; Zhai Y; He D; Chang Z
    Oncogene; 2017 Jul; 36(29):4191-4200. PubMed ID: 28346425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.